Clinical trial
A Feasibility Study of Non-Invasive Cerenkov Luminescence Imaging in Patients With Cancer
NCT03484884 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Feasibility Study of Non-Invasive Cerenkov Luminescence Imaging in Patients With Cancer
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 20, 2018
- Completion date
- March 31, 2027
- Enrollment
- 102 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
thyroid cancer